{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:46:10Z","timestamp":1792431970510,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1475-2875-9-357","type":"journal-article","created":{"date-parts":[[2010,12,9]],"date-time":"2010-12-09T14:15:27Z","timestamp":1291904127000},"source":"Crossref","is-referenced-by-count":127,"title":["The position of mefloquine as a 21st century malaria chemoprophylaxis"],"prefix":"10.1186","volume":"9","author":[{"given":"Patricia","family":"Schlagenhauf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Adamcova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Regep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin T","family":"Schaerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Georg","family":"Rhein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,9]]},"reference":[{"key":"1439_CR1","unstructured":"World Tourism Organisation (WTO): Tourism highlights 2008. [\n                    http:\/\/unwto.org\/facts\/eng\/pdf\/highlights\/UNWTO_Highlights08_en_HR.pdf\n                    \n                  ]"},{"key":"1439_CR2","first-page":"560","volume":"77","author":"P Muentener","year":"1999","unstructured":"Muentener P, Schlagenhauf P, Steffen R: Imported malaria in industrialized countries. Trends and perspectives. Bull World Health Organ. 1999, 77: 560-566.","journal-title":"Bull World Health Organ"},{"key":"1439_CR3","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.3201\/eid1511.091147","volume":"15","author":"P Gautret","year":"2009","unstructured":"Gautret P, Schlagenhauf P, Gaudart J, Castelli F, Brouqui P, von Sonnenburg F, Loutan L, Parola P, GeoSentinel Surveillance Network: Multicenter EuroTravNet\/GeoSentinel study of travel-related infectious diseases in Europe. Emerg Infect Dis. 2009, 15: 1783-1790.","journal-title":"Emerg Infect Dis"},{"key":"1439_CR4","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3201\/eid1103.040677","volume":"11","author":"HH Askling","year":"2005","unstructured":"Askling HH, Nilsson J, Tegnell A, Janzon R, Ekdahl K: Malaria risk in travelers. Emerg Infect Dis. 2005, 11: 436-441.","journal-title":"Emerg Infect Dis"},{"key":"1439_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2310\/7060.2003.31764","volume":"10","author":"P Schlagenhauf","year":"2003","unstructured":"Schlagenhauf P, Steffen R, Loutan L: Migrants as a major risk group for imported malaria in European countries. J Travel Med. 2003, 10: 106-107. 10.2310\/7060.2003.31764.","journal-title":"J Travel Med"},{"key":"1439_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3201\/eid1502.080712","volume":"15","author":"K St\u00e4ger","year":"2009","unstructured":"St\u00e4ger K, Legros F, Krause G, Low N, Bradley D, Desai M, Graf S, D'Amato S, Mizuno Y, Janzon R, Petersen E, Kester J, Steffen R, Schlagenhauf P: Imported malaria in children in industrialized countries, 1992-2002. Emerg Infect Dis. 2009, 15: 185-191.","journal-title":"Emerg Infect Dis"},{"key":"1439_CR7","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1086\/497697","volume":"192","author":"GP Maguire","year":"2005","unstructured":"Maguire GP, Handojo T, Pain MCF, Kenangalem E, Price RN, Tjitra E, Anstey NM: Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in Papua, Indonesia. JID. 2005, 192: 1966-74. 10.1086\/497697.","journal-title":"JID"},{"key":"1439_CR8","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.4269\/ajtmh.2006.75.1188","volume":"75","author":"D Christen","year":"2006","unstructured":"Christen D, Steffen R, Schlagenhauf P: Deaths caused by malaria in Switzerland 1988-2002. Am J Trop Med Hyg. 2006, 75: 1188-1194.","journal-title":"Am J Trop Med Hyg"},{"key":"1439_CR9","volume-title":"International Travel and Health","author":"World Health Organization","year":"2010","unstructured":"World Health Organization: Malaria. International Travel and Health. 2010, WHO, Geneva, [\n                    http:\/\/www.who.int\/ith\n                    \n                  ]"},{"key":"1439_CR10","volume-title":"Health Information for International Travel","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","unstructured":"Centers for Disease Control and Prevention (CDC): Malaria. Health Information for International Travel. 2010, Atlanta: US Department of Health and Human Services, Public Health Service"},{"key":"1439_CR11","volume-title":"Guidelines for malaria prevention in travellers from the United Kingdom","author":"P Chiodini","year":"2007","unstructured":"Chiodini P, Hill D, Lalloo D, Lea G, Walker E, Whitty C, Bannister B: Guidelines for malaria prevention in travellers from the United Kingdom. 2007, London, Health Protection Agency, [\n                    http:\/\/www.hpa.org.uk\/infections\/topics_az\/malaria\/ACMP.htm\n                    \n                  ]"},{"key":"1439_CR12","first-page":"1","volume":"30","author":"Health Canada","year":"2006","unstructured":"Health Canada: Canadian Recommendations for the Prevention and Treatment of Malaria Among International Travellers. Canada Comm Dis Rep. 2006, 30: 1-62. [\n                    http:\/\/www.phac-aspc.gc.ca\/publicat\/ccdr-rmtc\/04vol30\/30s1\/page3_e.html\n                    \n                  ]","journal-title":"Canada Comm Dis Rep"},{"key":"1439_CR13","volume-title":"Supplementum 1. BAG Bulletin","author":"C Hatz","year":"2006","unstructured":"Hatz C, Beck B, Blum J, Bourquin B, Brenneke F, Funk M, Genton G, Schlagenhauf P, Steffen R, Stoessl U: Malariaschutz f\u00fcr Kurzzeitaufenthalter. Supplementum 1. BAG Bulletin. 2006, [\n                    http:\/\/www.bag.admin.ch\/themen\/medizin\/00682\/00684\/02535\/index.html?lang=fr\n                    \n                  ]"},{"key":"1439_CR14","first-page":"234","volume":"21-22","author":"Institut de Veille Sanitaire, Republique Francaise","year":"2010","unstructured":"Institut de Veille Sanitaire, Republique Francaise: Sant\u00e9 des voyageurs et recommendations sanitaires 2010. Bulletin Epidemiologique Hebdomadaire. 2010, 21-22: 234-241.","journal-title":"Bulletin Epidemiologique Hebdomadaire"},{"key":"1439_CR15","unstructured":"Bialek R, Burchard G-D, Jelinek T, Nothdurft HD, Schonfeld C, Volkmer K-J: Empfehlungen Malariavorbeugung. Deutsche Gesellschaft f\u00fcr Tropenmedizin und Internationale Gesundheit (DTG), [\n                    http:\/\/www.dtg.org\n                    \n                  ]"},{"key":"1439_CR16","volume-title":"Therapeutic guidelines Ltd","author":"Australian Antibiotic Guidelines, Antibiotic version 13, 2006","year":"2006","unstructured":"Australian Antibiotic Guidelines, Antibiotic version 13, 2006: Therapeutic guidelines Ltd. 2006, North Melbourne, Australia"},{"key":"1439_CR17","first-page":"1","volume-title":"Malaria Prevention Guidelines for Japanese Travelers 2005","author":"Malaria Disease Prevention Committee","year":"2005","unstructured":"Malaria Disease Prevention Committee: Malaria Prevention Guidelines for Japanese Travelers 2005. 2005, Free Press, Tokyo, 1-43."},{"key":"1439_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1708-8305.1999.tb00843.x","volume":"6","author":"P Schlagenhauf","year":"1999","unstructured":"Schlagenhauf P: Mefloquine for malaria chemoprophylaxis 1992-1998: a review. J Travel Med. 1999, 6: 122-133. 10.1111\/j.1708-8305.1999.tb00843.x.","journal-title":"J Travel Med"},{"issue":"Suppl","key":"1439_CR19","first-page":"23","volume":"73","author":"PP Singh","year":"1981","unstructured":"Singh PP, Dutta GP: Antimalarial activity of mefloquine and chloroquine against blood induced Plasmodium knowlesi infection in rhesus monkeys. Indian J Med Res. 1981, 73 (Suppl): 23-28.","journal-title":"Indian J Med Res"},{"key":"1439_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1475-2875-8-15","volume":"8","author":"U Bronner","year":"2009","unstructured":"Bronner U, Divis PC, F\u00e4rnert A, Singh B: Swedish traveller with Plasmodium knowlesi malaria after visiting Malaysian Borneo. Malar J. 2009, 8: 15-10.1186\/1475-2875-8-15.","journal-title":"Malar J"},{"key":"1439_CR21","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1086\/514710","volume":"27","author":"GD Shanks","year":"1998","unstructured":"Shanks GD, Gordon DM, Klotz FW, Aleman GM, Oloo AJ, Sadie D, Scott TR: Efficacy and safety of atovaquone\/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria. Clin Infect Dis. 1998, 27: 494-499. 10.1086\/514710.","journal-title":"Clin Infect Dis"},{"key":"1439_CR22","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1136\/bmj.327.7423.1078","volume":"327","author":"P Schlagenhauf","year":"2003","unstructured":"Schlagenhauf P, Tschopp A, Johnson R, Nothdurft HD, Beck B, Schwartz E, Herold M, Krebs B, Veit O, Allwinn R, Stetffen R: Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study. BMJ. 2003, 327: 1078-1081. 10.1136\/bmj.327.7423.1078.","journal-title":"BMJ"},{"key":"1439_CR23","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0035-9203(99)90030-5","volume":"93","author":"D Baudon","year":"1999","unstructured":"Baudon D, Martet G, Pascal B, Bernhard J, Keundjian A, Laroche R: Efficacy of daily antimalarial chemoprophylaxis in tropical Africa using either doxycycline or chloroquine-proguanil; a study conducted in 1996 in the French Army. Trans R Soc Trop Med Hyg. 1999, 93: 302-303. 10.1016\/S0035-9203(99)90030-5.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1439_CR24","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","volume":"27","author":"K Smith","year":"2005","unstructured":"Smith K, Leyden JJ: Safety of doxycycline and minocycline: a systematic review. Clin Ther. 2005, 27: 1329-42. 10.1016\/j.clinthera.2005.09.005.","journal-title":"Clin Ther"},{"key":"1439_CR25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/1471-2334-10-279","volume":"10","author":"L Widmer","year":"2010","unstructured":"Widmer L, Blank P, Van Herck K, Hatz C, Schlagenhauf P: Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West Africa. BMC Infect Dis. 2010, 10: 279-10.1186\/1471-2334-10-279.","journal-title":"BMC Infect Dis"},{"key":"1439_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0169-4758(95)80201-0","volume":"11","author":"FP Mockenhaupt","year":"1995","unstructured":"Mockenhaupt FP: Mefloquine resistance in Plasmodium falciparum. Parasitol Today. 1995, 11: 248-253. 10.1016\/0169-4758(95)80201-0.","journal-title":"Parasitol Today"},{"key":"1439_CR27","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/0140-6736(93)93058-9","volume":"341","author":"HO Lobel","year":"1993","unstructured":"Lobel HO, Miani M, Eng T, Bernard KW, Hightower AW, Campbell CC: Long-term malaria prophylaxis with weekly mefloquine. Lancet. 1993, 341: 848-851. 10.1016\/0140-6736(93)93058-9.","journal-title":"Lancet"},{"key":"1439_CR28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4269\/ajtmh.1992.46.8","volume":"46","author":"P Brasseur","year":"1992","unstructured":"Brasseur P, Kouamouo J, Moyou-Somo R, Druilhe P: Multi-drug resistant falciparum malaria in Cameroon in 1987-1988. II Mefloquine resistance confirmed in vivo and in vitro and its correlation with quinine resistance. Am J Trop Med Hyg. 1992, 46: 8-14.","journal-title":"Am J Trop Med Hyg"},{"key":"1439_CR29","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1073\/pnas.91.3.1143","volume":"91","author":"AF Cowman","year":"1994","unstructured":"Cowman AF, Galatis D, Thompson JK: Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross resistance to halofantrine and quinine. Proc Nat Acad Sci USA. 1994, 91: 1143-1147. 10.1073\/pnas.91.3.1143.","journal-title":"Proc Nat Acad Sci USA"},{"key":"1439_CR30","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/35002615","volume":"403","author":"MB Reed","year":"2000","unstructured":"Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF: Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature. 2000, 403: 906-909. 10.1038\/35002615.","journal-title":"Nature"},{"key":"1439_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0035-9203(93)90434-R","volume":"87","author":"AM Oduola","year":"1993","unstructured":"Oduola AM, Omitowoju GO, Gerena L, Kyle DE, Milhous WK, Sowunmi A, Salako LA: Reversal of mefloquine resistance with penfluridol in isolates of Plasmodium falciparum from south-west Nigeria. Trans R Soc Trop Med Hyg. 1993, 87: 81-83. 10.1016\/0035-9203(93)90434-R.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1439_CR32","volume-title":"Use of mefloquine chemoprophylaxis by non-immune travelers before and during pregnancy. A critical evaluation of the evidence from 1985-2005","author":"P Schlagenhauf","year":"2006","unstructured":"Schlagenhauf P, Boutros Suarez M, Leuenberger T, Fr\u00f6hlich E: Use of mefloquine chemoprophylaxis by non-immune travelers before and during pregnancy. A critical evaluation of the evidence from 1985-2005. 2006, Abstract NECTM Edinburgh"},{"key":"1439_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-1-4419-0981-7_12","volume":"659","author":"S Rogerson","year":"2010","unstructured":"Rogerson S: Malaria in pregnancy and the newborn. Adv Exp Med Biol. 2010, 659: 139-152. full_text.","journal-title":"Adv Exp Med Biol"},{"key":"1439_CR34","volume-title":"A reference guide to fetal and neonatal risk. Drugs in pregnancy and lactation","author":"G Briggs","year":"2005","unstructured":"Briggs G, Freeman R, Yaffe S: A reference guide to fetal and neonatal risk. Drugs in pregnancy and lactation. 2005, Lippincott Williams & Wilkins. Philadelphia, 7","edition":"7"},{"key":"1439_CR35","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1046\/j.1365-3156.2003.01066.x","volume":"6","author":"RD Newman","year":"2003","unstructured":"Newman RD, Parise ME, Slutsker L, Nahlen B, Steketee RW: Safety, efficacy and determinants of the effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum endemic sub-Saharan Africa. Trop Med Internat Health. 2003, 6: 488-506. 10.1046\/j.1365-3156.2003.01066.x.","journal-title":"Trop Med Internat Health"},{"key":"1439_CR36","doi-asserted-by":"crossref","unstructured":"Orton L, Garner P: Drugs for treating uncomplicated malaria in pregnant women. Cochrane Database of Systematic Reviews. 2005, CD004912.pub2-3","DOI":"10.1002\/14651858.CD004912.pub2"},{"key":"1439_CR37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4269\/ajtmh.1998.58.17","volume":"58","author":"B Vanhauwere","year":"1998","unstructured":"Vanhauwere B, Maradit H, Kerr L: Postmarketing surveillance of prophylactic mefloquine (Lariam\u00ae) use in pregnancy. Am J Trop Med Hyg. 1998, 58: 17-21.","journal-title":"Am J Trop Med Hyg"},{"key":"1439_CR38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/GRF.0b013e318161d2c8","volume":"51","author":"B Fisher","year":"2008","unstructured":"Fisher B, Rose NC, Carey JC: Principles and practice of teratology for the obstetrician. Clin Obstet Gynecol. 2008, 51: 106-118. 10.1097\/GRF.0b013e318161d2c8.","journal-title":"Clin Obstet Gynecol"},{"key":"1439_CR39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s002280050100","volume":"50","author":"A Bourahla","year":"1996","unstructured":"Bourahla A, Martin C, Gimenez F, Singhasivanon V, Attanath P, Sabchearon A, Chongsuphajaisiddhi T, Farinotti R: Stereoselective pharmacokinetics of mefloquine in young children. Eur J Clin Pharmacol. 1996, 50: 241-244. 10.1007\/s002280050100.","journal-title":"Eur J Clin Pharmacol"},{"key":"1439_CR40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/02724936.1996.11747839","volume":"16","author":"C Luxemburger","year":"1996","unstructured":"Luxemburger C, Price RN, Nosten F, Ter Kuile FO, Chongsuphajaisiddhi T, White NJ: Mefloquine in infants and young children. Ann Trop Paediatr. 1996, 16: 281-286.","journal-title":"Ann Trop Paediatr"},{"key":"1439_CR41","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1001\/jama.296.18.2234","volume":"296","author":"L Chen","year":"2006","unstructured":"Chen L, Wilson ME, Schlagenhauf P: Prevention of malaria in long-term travelers. JAMA. 2006, 296: 2234-2244. 10.1001\/jama.296.18.2234.","journal-title":"JAMA"},{"key":"1439_CR42","doi-asserted-by":"publisher","first-page":"374","DOI":"10.2310\/7060.2004.19207","volume":"11","author":"J Knobloch","year":"2004","unstructured":"Knobloch J: Long-term malaria prophylaxis for travelers. J Travel Med. 2004, 11: 374-378. 10.2310\/7060.2004.19207.","journal-title":"J Travel Med"},{"issue":"Suppl 1","key":"1439_CR43","first-page":"S16","volume":"10","author":"D Overbosch","year":"2003","unstructured":"Overbosch D: Post-marketing surveillance: adverse events during long-term use of atovaquone\/proguanil for travellers to malaria endemic countries. J Travel Med. 2003, 10 (Suppl 1): S16-20.","journal-title":"J Travel Med"},{"key":"1439_CR44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1708-8305.2007.00116.x","volume":"14","author":"PJ van Genderen","year":"2007","unstructured":"van Genderen PJ, Koene HR, Spong K, Overbosch D: The safety and tolerance of atovaquone\/proguanil for the long-term prophylaxis of Plasmodium falciparum malaria non-immune travellers and expatriates. J Travel Med. 2007, 14: 92-95. 10.1111\/j.1708-8305.2007.00116.x.","journal-title":"J Travel Med"},{"issue":"Suppl 1","key":"1439_CR45","first-page":"13","volume":"10","author":"E Petersen","year":"2003","unstructured":"Petersen E: The safety of atovaquone\/proguanil in long-term prophylaxis of nonimmune adults. J Travel Med. 2003, 10 (Suppl 1): 13-15.","journal-title":"J Travel Med"},{"key":"1439_CR46","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/0035-9203(93)90036-P","volume":"87","author":"RA Pennie","year":"1993","unstructured":"Pennie RA, Koren G, Crevoisier C: Steady state pharmacokinetics of mefloquine in long-term travellers. Trans R Soc Trop Med Hyg. 1993, 87: 459-462. 10.1016\/0035-9203(93)90036-P.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1439_CR47","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jinf.2005.01.014","volume":"51","author":"A Sonmez","year":"2005","unstructured":"Sonmez A, Harlak A, Kilic S, Polat Z, Hayat L, Keskin O, Dogru T, Yilmaz MI, Acikel CH, Kocar IH: The efficacy and tolerability of doxycycline and mefloquine in malaria prophylaxis of the ISAF troops in Afghanistan. J Infect. 2005, 51: 253-258. 10.1016\/j.jinf.2005.01.014.","journal-title":"J Infect"},{"key":"1439_CR48","doi-asserted-by":"crossref","first-page":"744","DOI":"10.4269\/ajtmh.2006.74.744","volume":"74","author":"TS Wells","year":"2006","unstructured":"Wells TS, Smith TC, Smith B, Wang LZ, Hansen CJ, Reed RJ, Goldfinger WE, Corbeil TE, Spooner CN, Ryan MA: Mefloquine use and hospitalizations among US service members, 2002-2004. Am J Trop Med Hyg. 2006, 74: 744-749.","journal-title":"Am J Trop Med Hyg"},{"key":"1439_CR49","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1001\/jama.297.20.2251","volume":"297","author":"LH Chen","year":"2007","unstructured":"Chen LH, Wilson ME, Schlagenhauf P: Controversies and misconceptions in malaria chemoprophylaxis for travelers. JAMA. 2007, 297: 2251-2263. 10.1001\/jama.297.20.2251.","journal-title":"JAMA"},{"key":"1439_CR50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1708-8305.1996.tb00750.x","volume":"4","author":"ML Mittelholzer","year":"1996","unstructured":"Mittelholzer ML, Wall M, Steffen R, St\u00fcrchler D: Malaria prophylaxis in different age groups. J Travel Med. 1996, 4: 219-223. 10.1111\/j.1708-8305.1996.tb00750.x.","journal-title":"J Travel Med"},{"key":"1439_CR51","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1708-8305.1997.tb00798.x","volume":"4","author":"JC Handschin","year":"1997","unstructured":"Handschin JC, Wall M, Steffen R, St\u00fcrchler D: Tolerability and effectiveness of malaria chemoprophylaxis with mefloquine or chloroquine with or without co-medication. J Travel Med. 1997, 4: 121-127. 10.1111\/j.1708-8305.1997.tb00798.x.","journal-title":"J Travel Med"},{"key":"1439_CR52","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1128\/AAC.39.8.1892","volume":"39","author":"C Crevoisier","year":"1995","unstructured":"Crevoisier C, Joseph I, Fischer M, Graf H: Influence of hemodialysis on plasma concentration-time profiles of mefloquine in two patients with end-stage renal disease: a prophylactic drug monitoring study. Antimicrob Agents Chemother. 1995, 39: 1892-1895.","journal-title":"Antimicrob Agents Chemother"},{"key":"1439_CR53","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.clpt.2006.07.003","volume":"80","author":"AL Aarnoudse","year":"2006","unstructured":"Aarnoudse AL, van Schaik RH, Dieleman J, Molokhia M, van Riemsdijk MM, Ligthelm RJ, Overbosch D, van der Heiden IP, Stricker BH: MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine. Clin Pharmacol Ther. 2006, 80: 367-374. 10.1016\/j.clpt.2006.07.003.","journal-title":"Clin Pharmacol Ther"},{"key":"1439_CR54","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1708-8305.2008.00272.x","volume":"16","author":"P Schlagenhauf","year":"2009","unstructured":"Schlagenhauf P, Johnson R, Schwartz E, Nothdurft HD, Steffen R: Evaluation of mood profiles during malaria chemoprophylaxis. A randomized, double-blind, four-arm study. J Travel Med. 2009, 16: 42-45. 10.1111\/j.1708-8305.2008.00272.x.","journal-title":"J Travel Med"},{"key":"1439_CR55","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0035-9203(97)90101-2","volume":"91","author":"MS Pergallo","year":"1997","unstructured":"Pergallo MS, Sabatinelli G, Majori G, Cali G, Sarnicola G: Prevention and morbidity in non-immune subjects; a case-control study among Italian troops in Somalia and Mozambique, 1992-1994. Trans R Soc Trop Med Hyg. 1997, 91: 343-346. 10.1016\/S0035-9203(97)90101-2.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1439_CR56","doi-asserted-by":"crossref","unstructured":"Jacquerioz FA, Croft AM: Drugs for preventing malaria in travellers. The Cochrane Collaboration. 2009, 4","DOI":"10.1002\/14651858.CD006491.pub2"},{"key":"1439_CR57","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/0140-6736(93)90814-W","volume":"341","author":"R Steffen","year":"1993","unstructured":"Steffen R, Fuchs E, Schildknecht J, Naef U, Funk M, Schlagenhauf P, Phillips-Howard P, Nevill C, St\u00fcrchler D: Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet. 1993, 341: 1299-1303. 10.1016\/0140-6736(93)90814-W.","journal-title":"Lancet"},{"key":"1439_CR58","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/bmj.313.7056.525","volume":"313","author":"PJ Barrett","year":"1996","unstructured":"Barrett PJ, Emmins PD, Clarke PD, Bradley DJ: Comparasion of adverse events associated with the use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. BMJ. 1996, 313: 525-528.","journal-title":"BMJ"},{"key":"1439_CR59","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1086\/322694","volume":"33","author":"D Overbosch","year":"2001","unstructured":"Overbosch D, Schilthuis HS, Bienzle U, Behrens RH, Kain KC, Clarke PD, Toovey S, Knobloch J, Nothdurft HD, Roskell NS, Chulay JD: Atovaquone\/proguanil versus mefloquine for malaria prophylaxis in non-immune travelers: results from a randomized, double-blind study. Clin Infect Dis. 2001, 33: 1015-1021. 10.1086\/322694.","journal-title":"Clin Infect Dis"},{"key":"1439_CR60","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2165\/00002018-200427030-00005","volume":"27","author":"CR Meier","year":"2004","unstructured":"Meier CR, Wilcock K, Jick SS: The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials. Drug Safety. 2004, 27: 203-213. 10.2165\/00002018-200427030-00005.","journal-title":"Drug Safety"},{"key":"1439_CR61","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1708-8305.1996.tb00695.x","volume":"3","author":"MA Phillips","year":"1996","unstructured":"Phillips MA, Kass RB: User acceptability patterns for mefloquine and doxycycline malaria chemoprophylaxis. J Travel Med. 1996, 3: 40-45. 10.1111\/j.1708-8305.1996.tb00695.x.","journal-title":"J Travel Med"},{"key":"1439_CR62","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1046\/j.1365-3156.1996.d01-85.x","volume":"1","author":"P Schlagenhauf","year":"1996","unstructured":"Schlagenhauf P, Steffen R, Lobel H, Johnson R, Letz R, Tschopp A, Vranjes N, Bergqvist Y, Ericsson O, Hellgren U, Rombo L, Mannino S, Handschin J, St\u00fcrchler D: Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance. Trop Med Int Health. 1996, 1: 485-494. 10.1046\/j.1365-3156.1996.d01-85.x.","journal-title":"Trop Med Int Health"},{"key":"1439_CR63","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1086\/650575","volume":"50","author":"P Schlagenhauf","year":"2010","unstructured":"Schlagenhauf P, Chen LH, Wilson ME, Freedman DO, Tcheng D, Schwartz E, Pandey P, Weber R, Nadal D, Berger C, von Sonnenburg F, Keystone J, Leder K: Sex, gender and travel associated disease. Clin Infect Dis. 2010, 50: 826-832. 10.1086\/650575.","journal-title":"Clin Infect Dis"},{"key":"1439_CR64","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1179\/000349804225021262","volume":"6","author":"L Ollivier","year":"2004","unstructured":"Ollivier L, Tifratene K, Josse R, Keundjian A, Boutin JP: The relationship between body weight and tolerance to mefloquine prophylaxis in non-immune adults; results of a questionnaire-based study. Ann Trop Med Parasitol. 2004, 6: 639-641. 10.1179\/000349804225021262.","journal-title":"Ann Trop Med Parasitol"},{"key":"1439_CR65","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.tmaid.2008.12.004","volume":"7","author":"S Toovey","year":"2009","unstructured":"Toovey S: Mefloquine neurotoxicity: a literature review. Travel Med Infect Dis. 2009, 7: 2-6. 10.1016\/j.tmaid.2008.12.004.","journal-title":"Travel Med Infect Dis"},{"key":"1439_CR66","doi-asserted-by":"publisher","first-page":"12364","DOI":"10.1073\/pnas.0402044101","volume":"101","author":"SJ Cruikshank","year":"2004","unstructured":"Cruikshank SJ, Hopperstad M, Younger M, Connors BW, Spray DC, Srinivas M: Potent block of Cx36 and Cx50 gap junction channels by mefloquine. Proc Natl Acad Sci USA. 2004, 101: 12364-12369. 10.1073\/pnas.0402044101.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1439_CR67","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1111\/j.1528-1167.2009.02087.x","volume":"50","author":"LJ Voss","year":"2009","unstructured":"Voss LJ, Jacobson G, Sleigh JW, Steyn-Ross A, Steyn-Ross M: Excitatory effects of gap junction blockers on cerebral cortex seizure-like activity in rats and mice. Epilepsia. 2009, 50: 1971-1978. 10.1111\/j.1528-1167.2009.02087.x.","journal-title":"Epilepsia"},{"key":"1439_CR68","first-page":"58","volume":"37","author":"YT Pham","year":"1999","unstructured":"Pham YT, Nosten F, Farinotti R, White NJ, Gimenez F: Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria. Int J Clin Pharmacol Ther. 1999, 37: 58-61. Erratum in: Int J Clin Pharmacol Ther 1999, 37: 316.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1439_CR69","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/jps.2600830613","volume":"83","author":"F Gimenez","year":"1994","unstructured":"Gimenez F, Pennie RA, Koren G, Crevoisier C, Wainer IW, Farinotti R: Stereoselective pharmacokinetics of mefloquine in healthy Caucasians after multiple doses. J Pharm Sci. 1994, 83: 824-827. 10.1002\/jps.2600830613.","journal-title":"J Pharm Sci"},{"key":"1439_CR70","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1046\/j.1365-2125.1997.00633.x","volume":"44","author":"U Hellgren","year":"1997","unstructured":"Hellgren U, Berggren-Palme I, Bergqvist Y, Jerling M: Enantioselective pharmacokinetics of mefloquine during long-term intake of the prophylactic dose. Br J Clin Pharmacol. 1997, 44: 119-124. 10.1046\/j.1365-2125.1997.00633.x.","journal-title":"Br J Clin Pharmacol"},{"key":"1439_CR71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10142-009-0137-8","volume":"10","author":"DA Iacobas","year":"2010","unstructured":"Iacobas DA, Iacobas S, Thomas N, Spray DC: Sex-dependent gene regulatory networks of the heart rhythm. Funct Integr Genomics. 2010, 10: 73-86. 10.1007\/s10142-009-0137-8.","journal-title":"Funct Integr Genomics"},{"key":"1439_CR72","doi-asserted-by":"publisher","first-page":"963","DOI":"10.7326\/0003-4819-126-12-199706150-00006","volume":"126","author":"C Ohrt","year":"1997","unstructured":"Ohrt C, Ritchie Tl, Widjaja H, Shanks GD, Fitriadi J, Fryauff DJ, Handschin J, Tang D, Sandjaja B, Tjitra E, Hadiarso L, Watt G, Wignall FS: Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. Ann Intern Med. 1997, 126: 963-972.","journal-title":"Ann Intern Med"},{"key":"1439_CR73","first-page":"257","volume":"44","author":"E Boudreau","year":"1993","unstructured":"Boudreau E, Schuster B, Sanchez J, Shanks GD, Fitriadi J, Fryauff DJ, Handschin J, Tang D, Sandjaja B, Tjitra E, Hadiarso L, Watt G, Wignall FS: Tolerability of prophylactic Lariam regimens. Trop Med Parasit. 1993, 44: 257-265.","journal-title":"Trop Med Parasit"},{"key":"1439_CR74","first-page":"515","volume":"152","author":"RC Wittes","year":"1995","unstructured":"Wittes RC, Sagmur R: Adverse reactions to mefloquine associated with ethanol ingestion. Can Med Assoc J. 1995, 152: 515-517.","journal-title":"Can Med Assoc J"},{"key":"1439_CR75","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/pds.1879","volume":"19","author":"RL Nevin","year":"2010","unstructured":"Nevin RL: Mefloquine prescriptions in the presence of contraindications: prevalence among US military personnel deployed to Afghanistan, 2007. Pharmacoepidemiol Drug Safety. 2010, 19: 206-210. 10.1002\/pds.1879.","journal-title":"Pharmacoepidemiol Drug Safety"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-9-357.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1475-2875-9-357\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-9-357.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T01:06:48Z","timestamp":1548119208000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-9-357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1439"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-9-357","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]},"article-number":"357"}}